184 related articles for article (PubMed ID: 35392085)
1. Analysis of Plasma Using Flow Cytometry Reveals Increased Immune Cell-Derived Extracellular Vesicles in Untreated Relapsing-Remitting Multiple Sclerosis.
Blandford SN; Fudge NJ; Corkum CP; Moore CS
Front Immunol; 2022; 13():803921. PubMed ID: 35392085
[TBL] [Abstract][Full Text] [Related]
2. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
3. Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.
D'Amico E; Zanghì A; Parrinello NL; Romano A; Palumbo GA; Chisari CG; Toscano S; Raimondo FD; Zappia M; Patti F
Front Immunol; 2022; 13():819136. PubMed ID: 35273601
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients.
Boldrini VO; Marques AM; Quintiliano RPS; Moraes AS; Stella CRAV; Longhini ALF; Santos I; Andrade M; Ferrari B; Damasceno A; Carneiro RPD; Brandão CO; Farias AS; Santos LMB
Front Immunol; 2022; 13():750660. PubMed ID: 35197967
[TBL] [Abstract][Full Text] [Related]
5. CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.
Mazzucco M; Mannheim W; Shetty SV; Linden JR
Fluids Barriers CNS; 2022 Feb; 19(1):13. PubMed ID: 35135557
[TBL] [Abstract][Full Text] [Related]
6. Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease.
Soukup J; Kostelanská M; Kereïche S; Hujacová A; Pavelcová M; Petrák J; Kubala Havrdová E; Holada K
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628959
[TBL] [Abstract][Full Text] [Related]
7. Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Moyano AL; Li G; Boullerne AI; Feinstein DL; Hartman E; Skias D; Balavanov R; van Breemen RB; Bongarzone ER; Månsson JE; Givogri MI
J Neurosci Res; 2016 Dec; 94(12):1579-1587. PubMed ID: 27557608
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls.
Groen K; Maltby VE; Scott RJ; Tajouri L; Lechner-Scott J
Mult Scler Relat Disord; 2020 Oct; 45():102446. PubMed ID: 32805479
[TBL] [Abstract][Full Text] [Related]
9. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Romme Christensen J; Börnsen L; Hesse D; Krakauer M; Sørensen PS; Søndergaard HB; Sellebjerg F
J Neuroinflammation; 2012 Sep; 9():215. PubMed ID: 22978757
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients.
Golabi M; Fathi F; Samadi M; Hesamian MS; Eskandari N
Inflammation; 2022 Aug; 45(4):1815-1828. PubMed ID: 35347537
[TBL] [Abstract][Full Text] [Related]
11. Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Sellner J; Koczi W; Harrer A; Oppermann K; Obregon-Castrillo E; Pilz G; Wipfler P; Afazel S; Haschke-Becher E; Trinka E; Kraus J
Clin Exp Immunol; 2013 Sep; 173(3):381-9. PubMed ID: 23611040
[TBL] [Abstract][Full Text] [Related]
12. Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis.
Gutiérrez-Fernández M; de la Cuesta F; Tallón A; Cuesta I; Fernández-Fournier M; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E; Otero-Ortega L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445717
[TBL] [Abstract][Full Text] [Related]
13. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis.
Pieragostino D; Lanuti P; Cicalini I; Cufaro MC; Ciccocioppo F; Ronci M; Simeone P; Onofrj M; van der Pol E; Fontana A; Marchisio M; Del Boccio P
J Proteomics; 2019 Jul; 204():103403. PubMed ID: 31170500
[TBL] [Abstract][Full Text] [Related]
14. Altered Levels of Toll-Like Receptors in Circulating Extracellular Vesicles in Multiple Sclerosis.
Bhargava P; Nogueras-Ortiz C; Chawla S; Bæk R; Jørgensen MM; Kapogiannis D
Cells; 2019 Sep; 8(9):. PubMed ID: 31509962
[TBL] [Abstract][Full Text] [Related]
15. Circulating CD3
Oba R; Isomura M; Igarashi A; Nagata K
J Immunol Res; 2019; 2019():6720819. PubMed ID: 31205958
[TBL] [Abstract][Full Text] [Related]
16. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
[TBL] [Abstract][Full Text] [Related]
17. Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis.
Torres Iglesias G; Fernández-Fournier M; Botella L; Piniella D; Laso-García F; Carmen Gómez-de Frutos M; Chamorro B; Puertas I; Tallón Barranco A; Fuentes B; Alonso de Leciñana M; Alonso-López E; Bravo SB; Eugenia Miranda-Carús M; Montero-Calle A; Barderas R; Díez-Tejedor E; Gutiérrez-Fernández M; Otero-Ortega L
Brain Behav Immun; 2023 Oct; 113():44-55. PubMed ID: 37406976
[TBL] [Abstract][Full Text] [Related]
18. Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study.
Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Caputo D; Rovaris M; Pasanisi MB; Clerici M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614334
[TBL] [Abstract][Full Text] [Related]
19. Defective CD19+CD24
Cencioni MT; Ali R; Nicholas R; Muraro PA
Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
